Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155


Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.

Møller H, Coupland VH, Tataru D, Peake MD, Mellemgaard A, Round T, Baldwin DR, Callister MEJ, Jakobsen E, Vedsted P, Sullivan R, Spicer J.

Thorax. 2018 Mar 6. pii: thoraxjnl-2017-210710. doi: 10.1136/thoraxjnl-2017-210710. [Epub ahead of print]



Eckardt J, Jakobsen E, Licht PB.

Ann Thorac Surg. 2018 Feb;105(2):667. doi: 10.1016/j.athoracsur.2017.05.005. No abstract available.


Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

O'Shaughnessy J, Petrakova K, Sonke GS, Conte P, Arteaga CL, Cameron DA, Hart LL, Villanueva C, Jakobsen E, Beck JT, Lindquist D, Souami F, Mondal S, Germa C, Hortobagyi GN.

Breast Cancer Res Treat. 2018 Feb;168(1):127-134. doi: 10.1007/s10549-017-4518-8. Epub 2017 Nov 21.


Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators.

Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17.


Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group.

Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13.


Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.

Sonke GS, Hart LL, Campone M, Erdkamp F, Janni W, Verma S, Villanueva C, Jakobsen E, Alba E, Wist E, Favret AM, Bachelot T, Hegg R, Wheatley-Price P, Souami F, Sutradhar S, Miller M, Germa C, Burris HA.

Breast Cancer Res Treat. 2018 Feb;167(3):659-669. doi: 10.1007/s10549-017-4523-y. Epub 2017 Oct 22.


Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study.

Han HS, Diéras V, Robson M, Palácová M, Marcom PK, Jager A, Bondarenko I, Citrin D, Campone M, Telli ML, Domchek SM, Friedlander M, Kaufman B, Garber JE, Shparyk Y, Chmielowska E, Jakobsen EH, Kaklamani V, Gradishar W, Ratajczak CK, Nickner C, Qin Q, Qian J, Shepherd SP, Isakoff SJ, Puhalla S.

Ann Oncol. 2018 Jan 1;29(1):154-161. doi: 10.1093/annonc/mdx505.


Long-term prognosis for neck-shoulder pain and disorders: a 14-year follow-up study.

Jakobsen ELT, Biering K, Kærgaard A, Dalbøge A, Andersen JH.

Occup Environ Med. 2018 Feb;75(2):90-97. doi: 10.1136/oemed-2017-104422. Epub 2017 Aug 23.


Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial.

Ejlertsen B, Tuxen MK, Jakobsen EH, Jensen MB, Knoop AS, Højris I, Ewertz M, Balslev E, Danø H, Vestlev PM, Kenholm J, Nielsen DL, Bechmann T, Andersson M, Cold S, Nielsen HM, Maae E, Carlsen D, Mouridsen HT.

J Clin Oncol. 2017 Aug 10;35(23):2639-2646. doi: 10.1200/JCO.2017.72.3494. Epub 2017 Jun 29.


Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators.

N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. Erratum in: N Engl J Med. 2017 Aug 17;377(7):702.


Glycogen Shunt Activity and Glycolytic Supercompensation in Astrocytes May Be Distinctly Mediated via the Muscle Form of Glycogen Phosphorylase.

Jakobsen E, Bak LK, Walls AB, Reuschlein AK, Schousboe A, Waagepetersen HS.

Neurochem Res. 2017 Sep;42(9):2490-2494. doi: 10.1007/s11064-017-2267-z. Epub 2017 May 11.


The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.

Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallières E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, Bolejack V, Crowley JJ, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions.

J Thorac Oncol. 2017 Jul;12(7):1109-1121. doi: 10.1016/j.jtho.2017.04.011. Epub 2017 Apr 28.


History of Depression in Lung Cancer Patients: Impact of Delay.

Iachina M, Brønserud MM, Jakobsen E, Trosko O, Green A.

Clin Oncol (R Coll Radiol). 2017 Sep;29(9):585-592. doi: 10.1016/j.clon.2017.03.014. Epub 2017 Apr 13.


Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer - a register based cohort-study.

Iachina M, Jakobsen E, Fallesen AK, Green A.

BMC Health Serv Res. 2017 Apr 12;17(1):267. doi: 10.1186/s12913-017-2230-3.


Neck-Shoulder Pain and Work Status among Former Sewing Machine Operators: A 14-year Follow-up Study.

Jakobsen ELT, Biering K, Kærgaard A, Andersen JH.

J Occup Rehabil. 2018 Mar;28(1):80-88. doi: 10.1007/s10926-017-9702-5.


Body Topography Parcellates Human Sensory and Motor Cortex.

Kuehn E, Dinse J, Jakobsen E, Long X, Schäfer A, Bazin PL, Villringer A, Sereno MI, Margulies DS.

Cereb Cortex. 2017 Jul 1;27(7):3790-3805. doi: 10.1093/cercor/bhx026.


Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.

Eckardt J, Jakobsen E, Licht PB.

Ann Thorac Surg. 2017 Apr;103(4):1121-1125. doi: 10.1016/j.athoracsur.2016.09.109. Epub 2017 Jan 18.


General practice consultations, diagnostic investigations, and prescriptions in the year preceding a lung cancer diagnosis.

Guldbrandt LM, Møller H, Jakobsen E, Vedsted P.

Cancer Med. 2017 Jan;6(1):79-88. doi: 10.1002/cam4.965. Epub 2016 Nov 23.


The Danish Prostate Cancer Database.

Nguyen-Nielsen M, Høyer S, Friis S, Hansen S, Brasso K, Jakobsen EB, Moe M, Larsson H, Søgaard M, Nakano A, Borre M.

Clin Epidemiol. 2016 Oct 25;8:649-653. eCollection 2016. Review.


The Danish Lung Cancer Registry.

Jakobsen E, Rasmussen TR.

Clin Epidemiol. 2016 Oct 25;8:537-541. eCollection 2016. Review.

Supplemental Content

Loading ...
Support Center